Raily AESMED (02135) Announces No Changes in Issued Shares for February 2026

Bulletin Express
03/04

Raily Aesthetic Medicine International Holdings Limited reported that, as of 28 February 2026, its authorized share capital remains at 1.00 billion ordinary shares with a par value of USD 0.05 per share, totaling USD 50.00 million. No changes were recorded during the month.

The number of issued shares stays at 557.08 million with zero treasury shares. The public float requirement of 25% for the listed ordinary shares was confirmed to be met.

Under the existing share option scheme, 47.28 million share options were outstanding at the end of the month, with no changes and no new shares issued in February 2026.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10